Menu

    Something new is coming to the FEMOFLOR family - FEMOFLOR DeltaScreen

    15.09.2026

    Some tests show what's present. This one looks for the cause.

    This September, RIDACOM introduces FEMOFLOR® DeltaScreen – a comprehensive molecular assay for diagnosing infectious and inflammatory conditions of the female reproductive system.

    When you're looking for the cause of infection or inflammation, you don't need broad coverage. You need a focused answer. That's what FEMOFLOR® DeltaScreen is built to deliver.

    Different clinical questions call for different assays.

    Where FEMOFLOR® II maps the microbiome in full, FEMOFLOR® DeltaScreen takes on infection and inflammation, directly naming the organisms responsible.

    In a single analysis, FEMOFLOR® DeltaScreen covers:

    • quantitative vaginal microbiome profiling
    • opportunistic microorganisms
    • key sexually transmitted pathogens
    • herpesviruses – HSV-1, HSV-2 and CMV

    One targeted panel that turns a clinical suspicion into a clear, quantified answer.

    FEMOFLOR® DeltaScreen carries forward, and significantly advances, the role long served by FEMOFLOR® Screen. It sharpens the diagnostic picture with differentiation of Candida albicans, differentiation of Lactobacillus iners and Lactobacillus non-iners, and detection of Mycoplasma hominis.

    It also introduces a dedicated aerobic panel, new to the Screen line – covering Staphylococcus spp., Streptococcus spp., Enterobacteriaceae, Enterococcus spp. and Haemophilus spp., organisms that can play a decisive role in infection and inflammation.

    A familiar approach. Broader capabilities.

    To see FEMOFLOR® DeltaScreen in action, get in touch for a demonstration, a compatibility check for your instrument, or details on bringing it into your laboratory, we are always glad to help and to answer all of your questions.



    Files for download:
    Download Femoflor DeltaScreen Brochure